|
CNCR
|
Loncar Cancer Immunotherapy ETF
|
US
|
NASDAQ
|
|
CNTB
|
Connect Biopharma Holdings Limited
|
US
|
NASDAQ
|
|
COYA
|
Coya Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
US
|
NASDAQ
|
|
CRVS
|
Corvus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CUE
|
Cue Biopharma, Inc.
|
US
|
NASDAQ
|
|
CVM
|
Cel-Sci Corporation
|
US
|
AMEX
|
|
CYAN
|
Cyanotech Corporation
|
US
|
NASDAQ
|
|
DBVT
|
DBV Technologies S.A.
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
EDIT
|
Editas Medicine, Inc.
|
US
|
NASDAQ
|
|
ENLV
|
Enlivex Therapeutics Ltd.
|
US
|
NASDAQ
|
|
EQ
|
Equillium, Inc.
|
US
|
NASDAQ
|
|
ERNA
|
Eterna Therapeutics Inc.
|
US
|
NASDAQ
|
|
FBIO
|
Fortress Biotech, Inc.
|
US
|
NASDAQ
|
|
FSTX
|
F-star Therapeutics, Inc.
|
US
|
NASDAQ
|
|
GRCL
|
Gracell Biotechnologies Inc.
|
US
|
NASDAQ
|
|
GRTS
|
Gritstone Oncology, Inc.
|
US
|
NASDAQ
|
|
HARP
|
Harpoon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HGEN
|
Humanigen, Inc.
|
US
|
NASDAQ
|